Organogenesis (ORGO) and MiMedx (MDXG) traded lower on Friday after the Centers for Medicare & Medicaid Services (CMS) ...

Dec 26, 2025–Kerecis, the company pioneering the use of sustainably sourced fish skin in cellular therapy and tissue ...

Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company addressing age-related and degenerative diseases, today released comments by Robert J. Hariri, M.D., Ph.D., ...

MTF Biologics' AmnioBand® Membrane and AlloPatch® Pliable are among the 18 tissues that will be covered under the newly ...

The U.S. Centers for Medicare & Medicaid Services decided to peel back a series of local coverage determinations for skin substitute grafts that provoked a vigorous response from stakeholders.

Please provide your email address to receive an email when new articles are posted on . Five Medicare Administrative Contractors have withdrawn their final local coverage determinations for ...

MOUNTAIN VIEW, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and ...

CANTON, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of ...

Organogenesis (ORGO) commends the decision by the U.S. Centers for Medicare & Medicaid Services on local coverage determination based on peer-reviewed and evidence-based data of clinical efficacy. The ...

Please provide your email address to receive an email when new articles are posted on . WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye/Retina 2024, Nathan M. Radcliffe, MD, ...

Membrane and AlloPatch (R) Pliable are among the 18 tissues that will be covered under the newly updated Medicare Local Coverage Determinations (LCDs) for skin substitute grafts/cellular and ...